BLISS-LN: Belimumab in Lupus Nephritis
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis. Furie R, Rovin BH, Houssiau F, et al. N Engl J
Continue readingTwo-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis. Furie R, Rovin BH, Houssiau F, et al. N Engl J
Continue readingUpadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase
Continue readingTocilizumab Prevents Progression of Early Systemic Sclerosis Associated Interstitial Lung Disease Roofeh D, Lin CJF, Goldin J, et al. on
Continue reading“Trial of Tocilizumab in Giant-Cell Arteritis.“ Stone JH, Tuckwell K, Dimonaco S, et al. N Engl J Med. 2017 Jul
Continue reading“Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis” by the Aspreva Lupus Management Study (ALMS) Group JASN May
Continue reading“Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis” by the Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network (RAVE-ITN) Research Group N Engl J
Continue reading